首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
CeftazidimeAcquired drug resistance: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2025年
/ 2042卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-025-74910-8
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:111 / 111
相关论文
共 50 条
[41]
GefitinibAcquired drug resistance: case report
Reactions Weekly,
2021,
1866
(1)
: 187
-
187
[42]
TemozolomideHypermutagenesis and drug resistance: case report
Reactions Weekly,
2021,
1851
(1)
: 341
-
341
[43]
InfliximabDevelopment of drug resistance: case report
Reactions Weekly,
2021,
1847
(1)
: 244
-
244
[44]
BedaquilineEmergence of drug resistance: case report
Reactions Weekly,
2019,
1777
(1)
: 52
-
52
[45]
CrizotinibDevelopment of drug resistance: case report
Reactions Weekly,
2021,
1882
(1)
: 158
-
158
[46]
CrizotinibDevelopment of drug resistance: case report
Reactions Weekly,
2018,
1705
(1)
: 104
-
104
[47]
EmicizumabDevelopment of drug resistance: case report
Reactions Weekly,
2022,
1888
(1)
: 165
-
165
[48]
ImatinibThrombocytopenia and drug resistance: case report
Reactions Weekly,
2010,
1310
(1)
: 28
-
28
[49]
BlinatumomabDevelopment of drug resistance: case report
Reactions Weekly,
2021,
1847
(1)
: 101
-
101
[50]
MeropenemDevelopment of drug resistance: case report
Reactions Weekly,
2020,
1785
(1)
: 329
-
329
←
1
2
3
4
5
→